使用抗生素预防自发性细菌性腹膜炎:回顾与质量改进研究

GastroHep Pub Date : 2024-07-05 DOI:10.1155/2024/9271718
Ariana Tagliaferri, Nida Ansari, Gabriel Melki, Yana Cavanagh
{"title":"使用抗生素预防自发性细菌性腹膜炎:回顾与质量改进研究","authors":"Ariana Tagliaferri,&nbsp;Nida Ansari,&nbsp;Gabriel Melki,&nbsp;Yana Cavanagh","doi":"10.1155/2024/9271718","DOIUrl":null,"url":null,"abstract":"<p><b>Background:</b> Primary and secondary prophylaxis for spontaneous bacterial peritonitis (SBP) should be reserved for high-risk cirrhotic patients, such as those with a history of SBP, gastrointestinal (GI) hemorrhage, high Child–Pugh score, or low ascitic fluid protein (AFP) with liver and renal failure. Due to a multitude of reasons, many patients who require prophylaxis do not receive it. We present a retrospective analysis and quality improvement project. High-risk cirrhotic patients were identified to see if antibiotic prophylaxis was initiated upon admission and the 1-year outcomes for those individuals.</p><p><b>Methods and Results:</b> One hundred twenty-six patients were included in the study. The mean age was 57.38 years. A total of 59.5% (<i>n</i> = 75) of patients were current or former alcohol users. A total of 54.8% (<i>n</i> = 69) of patients met the criteria for SBP prophylaxis; however, only 26% (<i>n</i> = 18) received it (<i>p</i> ≤ 0.073). Ciprofloxacin and cephalosporins were the most used antibiotics. Although none of the analyses for readmissions produced statistical significance, there were clinically more patients readmitted for SBP when prophylaxis was not prescribed. No patients who received prophylaxis were hospitalized within 6 months following a discharge for SBP. Only two of the 18 patients who received prophylaxis died compared to 30 of the 51 patients who did not (<i>p</i> ≤ 0.001). Twenty-eight of the 32 who met the criteria but did not receive prophylaxis were deceased within 1 year following discharge (<i>p</i> ≤ 0.042). When stratified by basic demographics, mortality was significant in the nonprophylaxis groups for males (<i>p</i> ≤ 0.0001), 25–30 body mass index (BMI) group (<i>p</i> ≤ 0.003), and alcohol use (<i>p</i> ≤ 0.002).</p><p><b>Conclusion:</b> We intend to educate providers on the appropriate time to intervene to reduce mortality and subsequent hospitalizations for those with advanced liver disease.</p>","PeriodicalId":12480,"journal":{"name":"GastroHep","volume":"2024 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2024/9271718","citationCount":"0","resultStr":"{\"title\":\"The Use of Antibiotics for the Prophylaxis of Spontaneous Bacterial Peritonitis: A Retrospective Review and Quality Improvement Study\",\"authors\":\"Ariana Tagliaferri,&nbsp;Nida Ansari,&nbsp;Gabriel Melki,&nbsp;Yana Cavanagh\",\"doi\":\"10.1155/2024/9271718\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><b>Background:</b> Primary and secondary prophylaxis for spontaneous bacterial peritonitis (SBP) should be reserved for high-risk cirrhotic patients, such as those with a history of SBP, gastrointestinal (GI) hemorrhage, high Child–Pugh score, or low ascitic fluid protein (AFP) with liver and renal failure. Due to a multitude of reasons, many patients who require prophylaxis do not receive it. We present a retrospective analysis and quality improvement project. High-risk cirrhotic patients were identified to see if antibiotic prophylaxis was initiated upon admission and the 1-year outcomes for those individuals.</p><p><b>Methods and Results:</b> One hundred twenty-six patients were included in the study. The mean age was 57.38 years. A total of 59.5% (<i>n</i> = 75) of patients were current or former alcohol users. A total of 54.8% (<i>n</i> = 69) of patients met the criteria for SBP prophylaxis; however, only 26% (<i>n</i> = 18) received it (<i>p</i> ≤ 0.073). Ciprofloxacin and cephalosporins were the most used antibiotics. Although none of the analyses for readmissions produced statistical significance, there were clinically more patients readmitted for SBP when prophylaxis was not prescribed. No patients who received prophylaxis were hospitalized within 6 months following a discharge for SBP. Only two of the 18 patients who received prophylaxis died compared to 30 of the 51 patients who did not (<i>p</i> ≤ 0.001). Twenty-eight of the 32 who met the criteria but did not receive prophylaxis were deceased within 1 year following discharge (<i>p</i> ≤ 0.042). When stratified by basic demographics, mortality was significant in the nonprophylaxis groups for males (<i>p</i> ≤ 0.0001), 25–30 body mass index (BMI) group (<i>p</i> ≤ 0.003), and alcohol use (<i>p</i> ≤ 0.002).</p><p><b>Conclusion:</b> We intend to educate providers on the appropriate time to intervene to reduce mortality and subsequent hospitalizations for those with advanced liver disease.</p>\",\"PeriodicalId\":12480,\"journal\":{\"name\":\"GastroHep\",\"volume\":\"2024 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2024/9271718\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"GastroHep\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1155/2024/9271718\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"GastroHep","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/2024/9271718","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:自发性细菌性腹膜炎(SBP)的一级和二级预防应保留给高危肝硬化患者,如那些有 SBP 病史、消化道(GI)出血、Child-Pugh 评分高或腹水蛋白(AFP)低并伴有肝肾功能衰竭的患者。由于多种原因,许多需要预防性治疗的患者并未接受治疗。我们介绍一项回顾性分析和质量改进项目。我们对高危肝硬化患者进行了鉴定,以了解这些患者在入院时是否开始了抗生素预防治疗,以及这些患者一年后的治疗效果:研究共纳入 126 名患者。平均年龄为 57.38 岁。59.5%的患者(75 人)目前或曾经酗酒。共有 54.8%(n = 69)的患者符合 SBP 预防标准,但只有 26%(n = 18)的患者接受了预防(p ≤ 0.073)。环丙沙星和头孢菌素是使用最多的抗生素。虽然对再入院情况的分析都没有统计学意义,但临床上,未使用预防药物的 SBP 再入院患者更多。没有接受预防治疗的患者在因 SBP 出院后 6 个月内再次住院。接受预防治疗的 18 名患者中只有 2 人死亡,而未接受预防治疗的 51 名患者中有 30 人死亡(P ≤ 0.001)。符合标准但未接受预防性治疗的 32 名患者中有 28 人在出院后 1 年内死亡(p ≤ 0.042)。根据基本人口统计学特征进行分层后,未接受预防治疗组中男性(p ≤ 0.0001)、体重指数(BMI)25-30 组(p ≤ 0.003)和饮酒组(p ≤ 0.002)的死亡率显著高于未接受预防治疗组:我们希望教育医疗服务提供者在适当的时间进行干预,以降低晚期肝病患者的死亡率和后续住院率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

The Use of Antibiotics for the Prophylaxis of Spontaneous Bacterial Peritonitis: A Retrospective Review and Quality Improvement Study

The Use of Antibiotics for the Prophylaxis of Spontaneous Bacterial Peritonitis: A Retrospective Review and Quality Improvement Study

Background: Primary and secondary prophylaxis for spontaneous bacterial peritonitis (SBP) should be reserved for high-risk cirrhotic patients, such as those with a history of SBP, gastrointestinal (GI) hemorrhage, high Child–Pugh score, or low ascitic fluid protein (AFP) with liver and renal failure. Due to a multitude of reasons, many patients who require prophylaxis do not receive it. We present a retrospective analysis and quality improvement project. High-risk cirrhotic patients were identified to see if antibiotic prophylaxis was initiated upon admission and the 1-year outcomes for those individuals.

Methods and Results: One hundred twenty-six patients were included in the study. The mean age was 57.38 years. A total of 59.5% (n = 75) of patients were current or former alcohol users. A total of 54.8% (n = 69) of patients met the criteria for SBP prophylaxis; however, only 26% (n = 18) received it (p ≤ 0.073). Ciprofloxacin and cephalosporins were the most used antibiotics. Although none of the analyses for readmissions produced statistical significance, there were clinically more patients readmitted for SBP when prophylaxis was not prescribed. No patients who received prophylaxis were hospitalized within 6 months following a discharge for SBP. Only two of the 18 patients who received prophylaxis died compared to 30 of the 51 patients who did not (p ≤ 0.001). Twenty-eight of the 32 who met the criteria but did not receive prophylaxis were deceased within 1 year following discharge (p ≤ 0.042). When stratified by basic demographics, mortality was significant in the nonprophylaxis groups for males (p ≤ 0.0001), 25–30 body mass index (BMI) group (p ≤ 0.003), and alcohol use (p ≤ 0.002).

Conclusion: We intend to educate providers on the appropriate time to intervene to reduce mortality and subsequent hospitalizations for those with advanced liver disease.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信